On Wednesday, the U.S. Supreme Court will hear oral arguments in its most important case of the year, King v. Burwell. The case is most obviously significant because it could invalidate subsidies for low income individuals covered by Obamacare in the approximately two-thirds of states that did not establish their own exchanges.
Plugging personalized, or precision, medicine, President Obama recently announced funding for a new “research consortium” that would collect a variety of information from large numbers of people for a database. He failed to acknowledge, however, that the risk-averse posture and policies of his administration’s FDA create significant obstacles to the ultimate success of personalized medicine.
The current controversy over whether parents should be forced to have their children vaccinated for measles is one of the painful signs of our times. Measles was virtually wiped out in the United States, years ago. Why the resurgence of this disease now?
Following independent testing of herbal dietary supplements that found them to be fraudulently labeled, the New York Attorney General has sent cease-and-desist letters to major retailers, directing them to stop selling the products. Such action is long overdue, but it is insufficient.
Luigi Zingales of the University of Chicago talks with EconTalk host Russ Roberts on whether the financial sector is good for society and about the gap between how banks and bankers are perceived by the public vs. finance professors. Zingales discusses the costs and benefits of financial innovation, compares the finance sector to the health sector, and suggests how business education should talk about finance to create better behavior.
The Working Group on Health Care Policy devises public policies that enable more Americans to get better value for their health care dollar and foster appropriate innovations that will extend and improve life.